Search by Drug Name or NDC
NDC 46581-0830-06 Salonpas LIDOCAINE Pain Relieving 560 mg/1 Details
Salonpas LIDOCAINE Pain Relieving 560 mg/1
Salonpas LIDOCAINE Pain Relieving is a PERCUTANEOUS; TOPICAL; TRANSDERMAL PATCH in the HUMAN OTC DRUG category. It is labeled and distributed by Hisamitsu Pharmaceutical Co., Inc.. The primary component is LIDOCAINE.
MedlinePlus Drug Summary
Prescription lidocaine transdermal (Dermalid, Lidoderm, Ztildo) is used to relieve the pain of post-herpetic neuralgia (PHN; burning, stabbing pains, or aches that may last for months or years after a shingles infection). Nonprescription (over-the-counter) lidocaine (Absorbine Jr, Aspercreme, Lidocare, Salonpas, others) is also available to relieve minor pain in shoulders, arms, neck and legs in adults and children 12 years of age and older. Lidocaine is in a class of medications called local anesthetics. It works by stopping nerves from sending pain signals.
Related Packages: 46581-0830-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lidocaine Transdermal Patch
Product Information
| NDC | 46581-0830 |
|---|---|
| Product ID | 46581-830_39b310ac-4be6-4b3d-85a7-7d30c99ba7d1 |
| Associated GPIs | 90850060005920 |
| GCN Sequence Number | 023447 |
| GCN Sequence Number Description | lidocaine ADH. PATCH 4 % TOPICAL |
| HIC3 | Q5H |
| HIC3 Description | TOPICAL LOCAL ANESTHETICS |
| GCN | 60050 |
| HICL Sequence Number | 010705 |
| HICL Sequence Number Description | LIDOCAINE |
| Brand/Generic | Generic |
| Proprietary Name | Salonpas LIDOCAINE Pain Relieving |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | PATCH |
| Route | PERCUTANEOUS; TOPICAL; TRANSDERMAL |
| Active Ingredient Strength | 560 |
| Active Ingredient Units | mg/1 |
| Substance Name | LIDOCAINE |
| Labeler Name | Hisamitsu Pharmaceutical Co., Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part348 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 46581-0830-06 (46581083006)
| NDC Package Code | 46581-830-06 |
|---|---|
| Billing NDC | 46581083006 |
| Package | 6 POUCH in 1 BOX (46581-830-06) / 1 PATCH in 1 POUCH |
| Marketing Start Date | 2016-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 4f3a438c-f378-4d2a-a95c-58e56cf1e797 Details
Warnings
For external use only
Do not use
- more than one patch at a time
- on wounds or damaged skin
- with a heating pad
- if you are allergic to any igredients of this product
When using this product
- use only as directed
- avoid contact with the eyes, mucous membranes or rashes
- do not bandage tightly
Directions
Adults and children 12 years of age and over:
- clean and dry affected area
- remove film from patch and apply to the skin (see illustration)
- apply to affected are not more than 3 to 4 times daily
- remove patch from the skin after at most 8-hour application
Children under 12 years of age: consult a doctor
Inactive ingredients
Principal Display Panel
OTC topical analgesics in patch category*
WORLD'S BRAND NO.1
Hisamitsu
NDC#46581-830-06
Desensitize aggravated nerves
for temporary relief of pain
- Back
- Neck
- Shoulders
- Knees and Elbows
Salonpas LIDOCAINE 4% Pain Relieving Gel-Patch
APPLY FOR 8 HOURS
MAXIMUM STRENGTH*1
- Numbing Relief
- Unscented
6 PATCHES
3 15/16" X 5 1/2" (10cm X 14cm)
MADE IN JAPAN
Principal Display Panel
CUT OPEN HERE
NDC#46581-830-01
HOW TO APPLY
1 Pull apart.
2 Peel off one side of the film.
3 Place on affected area.
4 Peel off the remaining film.
5 Press patch thoroughly.
Salonpas LIDOCAINE 4% Pain Relieving Gel-Patch
APPLY FOR 8 HOURS
MAXIMUM STRENGTH*1
- Numbing Relief
- Unscented
1 PATCH
3 15/16" X 5 1/2" (10cm X 14cm)
Child-resistant packaging.
Hisamitsu
MADE IN JAPAN
INGREDIENTS AND APPEARANCE
| SALONPAS LIDOCAINE PAIN RELIEVING
lidocaine patch |
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
| Labeler - Hisamitsu Pharmaceutical Co., Inc. (690539713) |